Trial NCT01742793

View at ClinicalTrials.gov 
Org. Study IDs: 1112009392
Secondary IDs: 115541

Last trial update was posted on 2020-03-04

MeSH Interventions

Lenalidomide Romidepsin

MeSH Conditions

Hodgkin Disease Lymphoma Lymphoma, T-Cell Lymphoma, T-Cell, Peripheral Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions

Hodgkin's Lymphoma Mature T-cell Lymphoma

Stopping Reasons

The study was terminated due to withdrawal of institutional support, Phase II never began.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID